Skip to main content
. 2022 Aug 3;66(9):e00904-22. doi: 10.1128/aac.00904-22

TABLE 1.

Susceptibility (IC50) of rv0678 mutants to 16 antibioticsa

Antibiotic Target process Wild-type rv0678 138insG rv0678 274insA rv0678 C268T IC50 ratiob
PBTZ169 Arabinogalactan 1.7 6.6 7.1 4.1 4.2
BTZ043 Arabinogalactan 2.9 7.7 7.8 5 2.7
Bedaquiline ATP synthase 330 2700 2600 2100 7.9
Clofazimine Respiration 900 5400 4700 4000 5.2
Rifampicin Transcription 3.9 3.9 4 3.9 1.0
Isoniazid Mycolic acid 120 120 120 120 1.0
TCA-1 Arabinogalactan 480 610 630 570 1.3
IN-2 Arabinogalactan 730 770 780 760 1.1
Ethambutol Arabinogalactan 2400 2800 3200 3100 1.3
Levofloxacin DNA replication 700 700 700 690 1.0
Pretomanid Mycolic acid 360 400 430 440 1.2
Linezolid Translation 1300 1400 1300 1200 1.0
Streptomycin Translation 420 410 430 440 1.0
Amikacin Translation 930 900 950 980 1.0
Capreomycin Translation 1200 1200 1200 1200 1.0
Fusidic Acid Translation 4200 26000 26000 17000 6.2
a

IC50 values reflect drug concentrations in nanomolar (nM).

b

The IC50 ratio was calculated by dividing the IC50 for the rv0678 274insA mutant by the IC50 for the wild-type strain.